More than 1000 publications citing the use of Olink!
It has been quite the journey! Starting from the very first Target 96 Oncology I panel that we used in our first Olink study, branching out to both the focused, custom small biomarker panels with readout in absolute concentrations and the large exploratory Explore panels measuring thousands of proteins at once. Being early adopters of the PEA-technology has propelled our studies of protein biomarkers in relation to health and disease in ways we could not have imagined
Stefan Enroth, Associate Professor in Computational Genomics at Uppsala University, Sweden
The Olink multiplex PEA platform is a transformative -omics technology, enabling high throughput, highly multiplexed and precise protein analysis. As early adopters of PEA we have successfully used this to identify biomarkers for gynecological cancer. NGS has completely changed the genomics field. The Explore technology promises to be as transformative for the proteomics analysis. Coupling PEA with a NGS readout provides unprecedented opportunities for exhaustive analysis of the human proteome.
Ulf Gyllensten, Professor of Medical Molecular Genetics at Uppsala University, Sweden
Accelerate your approach to proteomics.
Introducing Olink® Insight
See data in new ways, collaborate faster and easier with peers, and access exclusive data sets.
Protein data points generated
Publications listed on website